{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:45:24Z","timestamp":1793148324548,"version":"4.5.0"},"reference-count":103,"publisher":"Radiation Research Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.1667\/rade-23-00196.1","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:35Z","timestamp":1713139235000},"source":"Crossref","is-referenced-by-count":34,"title":["Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures"],"prefix":"10.1667","volume":"201","author":[{"given":"Thomas A.","family":"Winters","sequence":"first","affiliation":[{"name":"Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libero","family":"Marzella","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Molinar-Inglis","sequence":"additional","affiliation":[{"name":"Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Price","sequence":"additional","affiliation":[{"name":"Office of Regulatory Affairs, DAIT, NIAID, NIH, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyun Calvin","family":"Han","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Jane","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony F.","family":"Fotenos","sequence":"additional","affiliation":[{"name":"Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Center for Devices for Radiological Health (CDRH), FDA, Silver Spring, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John I.","family":"Esker","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula J.","family":"Lapinskas","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"DiCarlo","sequence":"additional","affiliation":[{"name":"Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1243","reference":[{"key":"75","unstructured":"\"Emergency use authorization of medical products and related authorities.\"  (2017)"},{"key":"88","doi-asserted-by":"crossref","unstructured":"Z Wang, WL Yang, A Jacob, et al.  \"PLoS One.\"  10, \"Human Ghrelin mitigates intestinal injury and mortality after whole body irradiation in rats.\" e0118213 (2015)","DOI":"10.1371\/journal.pone.0118213"},{"key":"103","doi-asserted-by":"crossref","unstructured":"T Kumagai, F Rahman, AM Smith,  \"Nutrients.\"  10, \"The microbiome and radiation induced-bowel injury: Evidence for potential mechanistic role in disease pathogenesis.\" (2018)","DOI":"10.3390\/nu10101405"},{"key":"39","doi-asserted-by":"crossref","unstructured":"EB de Faria, KR Barrow, BT Ruehle, et al.  \"Health Phys.\"  109, \"The evolving Mcart multimodal imaging core: Establishing a protocol for computed tomography and echocardiography in the rhesus macaque to perform longitudinal analysis of radiation-induced organ injury.\" 479 (2015)","DOI":"10.1097\/HP.0000000000000344"},{"key":"54","doi-asserted-by":"crossref","unstructured":"\"Clin Pharmacol Ther.\"  69, \"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework.\" 89 (2001)","DOI":"10.1067\/mcp.2001.113989"},{"key":"62","unstructured":"\"Guidance for industry: Product development under the Animal Rule 2015 12\/7\/17.\""},{"key":"36","doi-asserted-by":"crossref","unstructured":"BL Fish, TJ MacVittie, F Gao, et al.  \"Health Phys.\"  121, \"Rat Models of partial-body irradiation with bone marrow-sparing (leg-out pbi) designed for FDA approval of countermeasures for mitigation of acute and delayed injuries by radiation.\" 419 (2021)","DOI":"10.1097\/HP.0000000000001444"},{"key":"76","doi-asserted-by":"crossref","unstructured":"J Van Dyk, TJ Keane, S Kan, et al.  \"Int J Radiat Oncol Biol Phys.\"  7, \"Radiation pneumonitis following large single dose irradiation: a re-evaluation based on absolute dose to lung.\" 461 (1981)","DOI":"10.1016\/0360-3016(81)90131-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"LP Taliaferro, DR Cassatt, ZP Horta, et al.  \"Radiat Res.\"  196, \"Meeting report: A poly-pharmacy approach to mitigate acute radiation syndrome.\" 436 (2021)","DOI":"10.1667\/RADE-21-00048.1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"C Booth, G Tudor, J Tudor, et al.  \"Health Phys.\"  103, \"Acute gastrointestinal syndrome in high-dose irradiated mice.\" 383 (2012)","DOI":"10.1097\/HP.0b013e318266ee13"},{"key":"12","doi-asserted-by":"crossref","unstructured":"JK Waselenko, TJ MacVittie, WF Blakely, et al.  \"Ann Intern Med.\"  140, \"Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.\" 1037 (2004)","DOI":"10.7326\/0003-4819-140-12-200406150-00015"},{"key":"42","doi-asserted-by":"crossref","unstructured":"TJ MacVittie, A Bennett, C Booth, et al.  \"Health Phys.\"  103, \"The prolonged gastrointestinal syndrome in rhesus macaques: the relationship between gastrointestinal, hematopoietic, and delayed multi-organ sequelae following acute, potentially lethal, partial-body irradiation.\" 427 (2012)","DOI":"10.1097\/HP.0b013e318266eb4c"},{"key":"23","doi-asserted-by":"crossref","unstructured":"M Hauer-Jensen, JW Denham, HJ Andreyev,  \"Nat Rev Gastroenterol Hepatol.\"  11, \"Radiation enteropathy\u2013pathogenesis, treatment and prevention.\" 470 (2014)","DOI":"10.1038\/nrgastro.2014.46"},{"key":"63","doi-asserted-by":"crossref","unstructured":"F Paris, Z Fuks, A Kang, et al.  \"Science.\"  293, \"Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice.\" 293 (2001)","DOI":"10.1126\/science.1060191"},{"key":"18","doi-asserted-by":"crossref","unstructured":"JS Trier  and TH Browning  \"J Clin Invest.\"  45, \"Morphologic response of the mucosa of human small intestine to X-ray exposure.\" 194 (1966)","DOI":"10.1172\/JCI105332"},{"key":"5","doi-asserted-by":"crossref","unstructured":"S Kulkarni, TC Wang, C Guha,  \"Curr Pathobiol Rep.\"  4, \"Stromal progenitor cells in mitigation of non-hematopoietic radiation injuries.\" 221 (2016)","DOI":"10.1007\/s40139-016-0114-6"},{"key":"2","doi-asserted-by":"crossref","unstructured":"P Gourmelon, M Benderitter, JM Bertho, et al.  \"Health Phys.\"  98, \"European consensus on the medical management of acute radiation syndrome and analysis of the radiation accidents in Belgium and Senegal.\" 825 (2010)","DOI":"10.1097\/HP.0b013e3181ce64d4"},{"key":"9","doi-asserted-by":"crossref","unstructured":"M Guo, Z Dong, J Qiao, et al.  \"J Radiat Res.\"  55, \"Severe acute radiation syndrome: treatment of a lethally 60Co-source irradiated accident victim in China with HLA-mismatched peripheral blood stem cell transplantation and mesenchymal stem cells.\" 205 (2014)","DOI":"10.1093\/jrr\/rrt102"},{"key":"15","doi-asserted-by":"crossref","unstructured":"N Dainiak, RN Gent, Z Carr, et al.  \"Disaster Med Public Health Prep.\"  5, \"Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.\" 183 (2011)","DOI":"10.1001\/dmp.2011.73"},{"key":"3","doi-asserted-by":"crossref","unstructured":"P Bhanja, S Saha, R Kabarriti, et al.  \"PLoS One.\"  4, \"Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice.\" e8014 (2009)","DOI":"10.1371\/journal.pone.0008014"},{"key":"41","doi-asserted-by":"crossref","unstructured":"AM Farese, AW Bennett, AM Gibbs, et al.  \"Health Phys.\"  116, \"Efficacy of Neulasta or Neupogen on H-ARS and GI-ARS mortality and hematopoietic recovery in nonhuman primates after 10-Gy irradiation with 2.5% bone marrow sparing.\" 339 (2019)","DOI":"10.1097\/HP.0000000000000878"},{"key":"101","doi-asserted-by":"crossref","unstructured":"N. Dainiak,  \"J Radiat Res.\"  59, \"Medical management of acute radiation syndrome and associated infections in a high-casualty incident.\" ii54 (2018)","DOI":"10.1093\/jrr\/rry004"},{"key":"89","doi-asserted-by":"crossref","unstructured":"KG Shah, R Wu, A Jacob, et al.  \"Mol Med.\"  15, \"Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis.\" 407 (2009)","DOI":"10.2119\/molmed.2009.00100"},{"key":"61","doi-asserted-by":"crossref","unstructured":"P Crenn, B Messing, L Cynober,  \"Clin Nutr.\"  27, \"Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.\" 328 (2008)","DOI":"10.1016\/j.clnu.2008.02.005"},{"key":"90","doi-asserted-by":"crossref","unstructured":"JG Kiang, MN Anderson, JT Smith,  \"Cell Biosci.\"  8, \"Ghrelin therapy mitigates bone marrow injury and splenocytopenia by sustaining circulating G-CSF and KC increases after irradiation combined with wound.\" 27 (2018)","DOI":"10.1186\/s13578-018-0225-3"},{"key":"91","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, PJ Liao, et al.  \"Oxid Med Cell Longev.\"  2014, \"Ghrelin therapy improves survival after whole-body ionizing irradiation or combined with burn or wound: amelioration of leukocytopenia, thrombocytopenia, splenomegaly, and bone marrow injury.\" 215858 (2014)","DOI":"10.1155\/2014\/215858"},{"key":"50","doi-asserted-by":"crossref","unstructured":"T Shea-Donohue, A Fasano, A Zhao, et al.  \"Radiat Res.\"  185, \"mechanisms involved in the development of the chronic gastrointestinal syndrome in nonhuman primates after total-body irradiation with bone marrow shielding.\" 591 (2016)","DOI":"10.1667\/RR14024.1"},{"key":"45","doi-asserted-by":"crossref","unstructured":"TJ MacVittie, AM Farese, GA Parker, et al.  \"Health Phys.\"  116, \"The gastrointestinal subsyndrome of the acute radiation syndrome in rhesus macaques: A systematic review of the lethal dose-response relationship with and without medical management.\" 305 (2019)","DOI":"10.1097\/HP.0000000000000903"},{"key":"44","doi-asserted-by":"crossref","unstructured":"GA Parker, N Li, K Takayama, et al.  \"Health Phys.\"  116, \"Histopathological features of the development of intestine and mesenteric lymph node injury in a nonhuman primate model of partial-body irradiation with minimal bone marrow sparing.\" 426 (2019)","DOI":"10.1097\/HP.0000000000000932"},{"key":"49","doi-asserted-by":"crossref","unstructured":"JW Jones, A Bennett, CL Carter, et al.  \"Health Phys.\"  109, \"Citrulline as a biomarker in the non-human primate total- and partial-body irradiation models: Correlation of circulating citrulline to acute and prolonged gastrointestinal injury.\" 440 (2015)","DOI":"10.1097\/HP.0000000000000347"},{"key":"26","doi-asserted-by":"crossref","unstructured":"KS Yan, LA Chia, X Li, et al.  \"Proc Natl Acad Sci U S A.\"  109, \"The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations.\" 466 (2012)","DOI":"10.1073\/pnas.1118857109"},{"key":"56","doi-asserted-by":"crossref","unstructured":"P Kumar, P Wang, G Tudor, et al.  \"Health Phys.\"  119, \"Evaluation of plasma biomarker utility for the gastrointestinal acute radiation syndrome in non-human primates after partial body irradiation with minimal bone marrow sparing through correlation with tissue and histological analyses.\" 594 (2020)","DOI":"10.1097\/HP.0000000000001348"},{"key":"60","doi-asserted-by":"crossref","unstructured":"J Wang, L Shao, HP Hendrickson, et al.  \"Radiat Res.\"  184, \"Total body irradiation in the \u201chematopoietic\u201d dose range induces substantial intestinal injury in non-human primates.\" 545 (2015)","DOI":"10.1667\/RR14191.1"},{"key":"19","doi-asserted-by":"crossref","unstructured":"AS Darwich, U Aslam, DM Ashcroft, et al.  \"Drug Metab Dispos.\"  42, \"Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans.\" 2016 (2014)","DOI":"10.1124\/dmd.114.058404"},{"key":"94","doi-asserted-by":"crossref","unstructured":"X Zhang, R Fisher, W Hou, et al.  \"Vivo.\"  34, \"Second-generation Probiotics Producing IL-22 Increase Survival of Mice After Total Body Irradiation.\" 39 (2020)","DOI":"10.21873\/invivo.11743"},{"key":"96","doi-asserted-by":"crossref","unstructured":"A Espinal, MW Epperly, A Mukherjee, et al.  \"Int J Mol Sci.\"  23, \"Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic.\" (2022)","DOI":"10.3390\/ijms23105616"},{"key":"95","doi-asserted-by":"crossref","unstructured":"DF Hamade, MW Epperly, R Fisher, et al.  \"Cancers.\"  15, \"Release of Interferon-\u03b2 (IFN-\u03b2) from probiotic Limosilactobacillus reuteri-IFN-\u03b2 (LR-IFN-\u03b2) mitigates gastrointestinal acute radiation syndrome (GI-ARS) following whole abdominal irradiation.\" (2023)","DOI":"10.3390\/cancers15061670"},{"key":"34","doi-asserted-by":"crossref","unstructured":"BI Bell, J Vercellino, NP Brodin, et al.  \"Cancer Res.\"  82, \"Orthovoltage X-rays exhibit increased efficacy compared with \u03b3-rays in preclinical irradiation.\" 2678 (2022)","DOI":"10.1158\/0008-5472.CAN-22-0656"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Y Poirier, MD Belley, MW Dewhirst, et al.  \"Radiat Res.\"  193, \"Transitioning from gamma rays to X-rays for comparable biomedical research irradiations: Energy matters.\" 506 (2020)","DOI":"10.1667\/RADE-20-00039.1"},{"key":"69","doi-asserted-by":"crossref","unstructured":"CJ Kurkjian, H Guo, ND Montgomery, et al.  \"Sci Rep.\"  7, \"The toll-like receptor 2\/6 agonist, fsl-1 lipopeptide, therapeutically mitigates acute radiation syndrome.\" 17355 (2017)","DOI":"10.1038\/s41598-017-17729-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"VP Kumar, K Wuddie, A Tsioplaya, et al.  \"Radiat Res.\"  201, \"Development of a Multi-Organ Radiation Injury Model with Precise Dosimetry with Focus on GI-ARS.\" 19 (2024)","DOI":"10.1667\/RADE-23-00068.1"},{"key":"102","doi-asserted-by":"crossref","unstructured":"TA Winters, DR Cassatt, JR Harrison-Peters, et al.  \"Radiat Res.\"  199, \"Considerations of medical preparedness to assess and treat various populations during a radiation public health emergency.\" 301 (2023)","DOI":"10.1667\/RADE-22-00148.1"},{"key":"68","doi-asserted-by":"publisher","unstructured":"H Guo, WC Chou, Y Lai, et al.  \"Science.\"  370, \"Multi-omics analyses of radiation survivors identify radioprotective microbes and metabolites.\" (2020)","DOI":"10.1126\/science.aay9097"},{"key":"1","doi-asserted-by":"crossref","unstructured":"HJ Andreyev, SE Davidson, C Gillespie, et al.  \"Gut.\"  61, \"Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer.\" 179 (2012)","DOI":"10.1136\/gutjnl-2011-300563"},{"key":"4","doi-asserted-by":"crossref","unstructured":"S Saha, P Bhanja, R Kabarriti, et al.  \"PLoS One.\"  6, \"Bone marrow stromal cell transplantation mitigates radiation-induced gastrointestinal syndrome in mice.\" e24072 (2011)","DOI":"10.1371\/journal.pone.0024072"},{"key":"6","doi-asserted-by":"crossref","unstructured":"S Saha, P Bhanja, L Liu, et al.  \"PLoS One.\"  7, \"TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.\" e29357 (2012)","DOI":"10.1371\/journal.pone.0029357"},{"key":"7","doi-asserted-by":"crossref","unstructured":"RE Goans  and N Wald  \"BJR Suppl.\"  27, \"Radiation accidents with multi-organ failure in the United States.\" 41 (2005)","DOI":"10.1259\/bjr\/27824773"},{"key":"8","unstructured":"DC. White,  \"An atlas of radiation histopathology.\"  (1975)"},{"key":"10","unstructured":"T.M. Fliedner  and I., K. B. Friesecke  \"Medical management of radiation accidents: manual on the acute radiation syndrome (METREPOL European Commission concerted action).\"  1 (2001)"},{"key":"11","doi-asserted-by":"crossref","unstructured":"O Molinar-Inglis, AL DiCarlo, PJ Lapinskas, et al.  \"Int J Radiat Biol.\"  \"Radiation-induced multi-organ injury.\" 2024","DOI":"10.1080\/09553002.2023.2295298"},{"key":"13","doi-asserted-by":"crossref","unstructured":"L Moussa, B Usunier, C Demarquay, et al.  \"Cell Transplant.\"  \"Bowel radiation injury: complexity of the pathophysiology and promises of cell and tissue engineering.\" (2016)","DOI":"10.3727\/096368916X691664"},{"key":"16","unstructured":"VI. Deribas,  \"Tsitologiia.\"  18, \"[Use of weak picric acid solutions for preparation of frozen sections].\" 365 (1976)"},{"key":"17","unstructured":"S. Tarpila,  \"Scand J Gastroenterol Suppl.\"  12, \"Morphological and functional response of human small intestine to ionizing irradiation.\" 1 (1971)"},{"key":"20","doi-asserted-by":"crossref","unstructured":"CS. Potten,  \"Philos Trans R Soc Lond B Biol Sci.\"  353, \"Stem cells in gastrointestinal epithelium: numbers, characteristics and death.\" 821 (1998)","DOI":"10.1098\/rstb.1998.0246"},{"key":"21","doi-asserted-by":"crossref","unstructured":"S. Umar,  \"Curr Gastroenterol Rep.\"  12, \"Intestinal stem cells.\" 340 (2010)","DOI":"10.1007\/s11894-010-0130-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"S. Umar,  \"Curr Gastroenterol Rep.\"  12, \"Intestinal stem cells.\" 340 (2010)","DOI":"10.1007\/s11894-010-0130-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"JM Novak, JT Collins, M Donowitz, et al.  \"J Clin Gastroenterol.\"  1, \"Effects of radiation on the human gastrointestinal tract.\" 9 (1979)","DOI":"10.1097\/00004836-197903000-00003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Y Huang, F Guo, D Yao, et al.  \"J Surg Res.\"  204, \"Surgery for chronic radiation enteritis: outcome and risk factors.\" 335 (2016)","DOI":"10.1016\/j.jss.2016.05.014"},{"key":"25","doi-asserted-by":"crossref","unstructured":"DH Scoville, T Sato, XC He, et al.  \"Gastroenterology.\"  134, \"Current view: intestinal stem cells and signaling.\" 849 (2008)","DOI":"10.1053\/j.gastro.2008.01.079"},{"key":"28","unstructured":"MT Wong, JF Lim, KS Ho, et al.  \"Singapore Med J.\"  51, \"Radiation proctitis: a decade's experience.\" 315 (2010)"},{"key":"30","doi-asserted-by":"crossref","unstructured":"JG Kiang, M Zhai, DL Bolduc, et al.  \"Radiat Res.\"  188, \"Combined therapy of pegylated G-CSF and Alxn4100TPO improves survival and mitigates acute radiation syndrome after whole-body ionizing irradiation alone and followed by wound trauma.\" 556 (2017)","DOI":"10.1667\/RR14647.1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"CJ Chiu, AH McArdle, R Brown, et al.  \"Arch Surg.\"  101, \"Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal.\" 478 (1970)","DOI":"10.1001\/archsurg.1970.01340280030009"},{"key":"35","doi-asserted-by":"crossref","unstructured":"T Beach, J Bakke, E Riccio, et al.  \"Int J Radiat Biol.\"  99, \"The progression of radiation injury in a Wistar rat model of partial body irradiation with \u223c5% bone marrow shielding.\" 1080 (2023)","DOI":"10.1080\/09553002.2023.2188937"},{"key":"37","doi-asserted-by":"crossref","unstructured":"M Doyle-Eisele, J Brower, K Aiello, et al.  \"Int J Radiat Biol.\"  97, \"Developing and comparing models of hematopoietic-acute radiation syndrome in G\u00f6ttingen and Sinclair minipigs.\" S73 (2021)","DOI":"10.1080\/09553002.2020.1820604"},{"key":"38","doi-asserted-by":"crossref","unstructured":"EP Cohen, AM Farese, GA Parker, et al.  \"Health Phys.\"  119, \"Lack of cellular inflammation in a non-human primate model of radiation nephropathy.\" 588 (2020)","DOI":"10.1097\/HP.0000000000001329"},{"key":"40","doi-asserted-by":"crossref","unstructured":"TJ MacVittie, AM Farese, MA Kane,  \"Health Phys.\"  116, \"ARS, DEARE, and multiple-organ injury: a strategic and tactical approach to link radiation effects, animal models, medical countermeasures, and biomarker development to predict clinical outcome.\" 297 (2019)","DOI":"10.1097\/HP.0000000000001045"},{"key":"43","doi-asserted-by":"crossref","unstructured":"AM Farese, C Booth, GL Tudor, et al.  \"Health Phys.\"  121, \"The natural history of acute radiation-induced H-ARS and concomitant multi-organ injury in the non-human primate: the MCART experience.\" 282 (2021)","DOI":"10.1097\/HP.0000000000001451"},{"key":"46","doi-asserted-by":"crossref","unstructured":"P Crenn, C Coudray-Lucas, F Thuillier, et al.  \"Gastroenterology.\"  119, \"Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.\" 1496 (2000)","DOI":"10.1053\/gast.2000.20227"},{"key":"47","doi-asserted-by":"crossref","unstructured":"G Jianfeng, Z Weiming, L Ning, et al.  \"J Surg Res.\"  127, \"Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.\" 177 (2005)","DOI":"10.1016\/j.jss.2005.04.004"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Y Wakabayashi, E Yamada, T Yoshida, et al.  \"Am J Physiol.\"  269, \"Effect of intestinal resection and arginine-free diet on rat physiology.\" G313 (1995)","DOI":"10.1152\/ajpgi.1995.269.2.G313"},{"key":"51","doi-asserted-by":"crossref","unstructured":"A Fernandes, A Oliveira, R Soares, et al.  \"Nutrients.\"  13, \"The effects of ionizing radiation on gut microbiota, a systematic review.\" (2021)","DOI":"10.3390\/nu13093025"},{"key":"52","doi-asserted-by":"crossref","unstructured":"J Liu, C Liu, J Yue,  \"Radiat Oncol.\"  16, \"Radiotherapy and the gut microbiome: facts and fiction.\" 9 (2021)","DOI":"10.1186\/s13014-020-01735-9"},{"key":"53","doi-asserted-by":"crossref","unstructured":"M Tonneau, A Elkrief, D Pasquier, et al.  \"Radiother Oncol.\"  156, \"The role of the gut microbiome on radiation therapy efficacy and gastrointestinal complications: A systematic review.\" 1 (2021)","DOI":"10.1016\/j.radonc.2020.10.033"},{"key":"55","doi-asserted-by":"crossref","unstructured":"TJ MacVittie, AM Farese, A Bennett, et al.  \"Health Physics.\"  103, \"The acute gastrointestinal subsyndrome of the acute radiation syndrome: A rhesus macaque model.\" 411 (2012)","DOI":"10.1097\/HP.0b013e31826525f0"},{"key":"57","doi-asserted-by":"crossref","unstructured":"JW Jones, G Tudor, F Li, et al.  \"Health Phys.\"  109, \"Citrulline as a biomarker in the murine total-body irradiation model: correlation of circulating and tissue citrulline to small intestine epithelial histopathology.\" 452 (2015)","DOI":"10.1097\/HP.0000000000000346"},{"key":"58","doi-asserted-by":"crossref","unstructured":"JW Jones, G Tudor, A Bennett, et al.  \"Anal Bioanal Chem.\"  406, \"Development and validation of a LC-MS\/MS assay for quantitation of plasma citrulline for application to animal models of the acute radiation syndrome across multiple species.\" 4663 (2014)","DOI":"10.1007\/s00216-014-7870-0"},{"key":"59","doi-asserted-by":"crossref","unstructured":"JW Jones, AJ Scott, G Tudor, et al.  \"Health Phys.\"  106, \"Identification and quantitation of biomarkers for radiation-induced injury via mass spectrometry.\" 106 (2014)","DOI":"10.1097\/HP.0b013e3182a4ed3b"},{"key":"64","doi-asserted-by":"crossref","unstructured":"CS Ferranti, J Cheng, C Thompson, et al.  \"J Cell Biol.\"  2020, \"Fusion of lysosomes to plasma membrane initiates radiation-induced apoptosis.\" 219","DOI":"10.1083\/jcb.201903176"},{"key":"65","doi-asserted-by":"crossref","unstructured":"P Santana, LA Pe\u00f1a, A Haimovitz-Friedman, et al.  \"Cell.\"  86, \"Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis.\" 189 (1996)","DOI":"10.1016\/S0092-8674(00)80091-4"},{"key":"66","doi-asserted-by":"crossref","unstructured":"J Rotolo, B Stancevic, J Zhang, et al.  \"J Clin Invest.\"  122, \"Anti-ceramide antibody prevents the radiation gastrointestinal syndrome in mice.\" 1786 (2012)","DOI":"10.1172\/JCI59920"},{"key":"67","doi-asserted-by":"crossref","unstructured":"JA Rotolo, CS Fong, S Bodo, et al.  \"JCI Insight.\"  6, \"Anti-ceramide single-chain variable fragment mitigates radiation GI syndrome mortality independent of DNA repair.\" (2021)","DOI":"10.1172\/jci.insight.145380"},{"key":"70","doi-asserted-by":"crossref","unstructured":"ED Bankaitis, A Ha, CJ Kuo, et al.  \"Gastroenterology.\"  155, \"Reserve stem cells in intestinal homeostasis and injury.\" 1348 (2018)","DOI":"10.1053\/j.gastro.2018.08.016"},{"key":"71","doi-asserted-by":"crossref","unstructured":"K Murata, U Jadhav, S Madha, et al.  \"Cell Stem Cell.\"  26, \"Ascl2-dependent cell dedifferentiation drives regeneration of ablated intestinal stem cells.\" 377 (2020)","DOI":"10.1016\/j.stem.2019.12.011"},{"key":"72","doi-asserted-by":"crossref","unstructured":"A Ayyaz, S Kumar, B Sangiorgi, et al.  \"Nature.\"  569, \"Single-cell transcriptomes of the regenerating intestine reveal a revival stem cell.\" 121 (2019)","DOI":"10.1038\/s41586-019-1154-y"},{"key":"73","doi-asserted-by":"crossref","unstructured":"RA Shivdasani, H Clevers, FJ de Sauvage,  \"Science.\"  371, \"Tissue regeneration: reserve or reverse?\" 784 (2021)","DOI":"10.1126\/science.abb6848"},{"key":"74","doi-asserted-by":"crossref","unstructured":"S Wang, L Zhou, L Ling, et al.  \"Front Immunol.\"  11, \"The crosstalk between Hippo-YAP pathway and innate immunity.\" 323 (2020)","DOI":"10.3389\/fimmu.2020.00323"},{"key":"78","unstructured":"\"M3(R2) Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.\"  (2010)"},{"key":"79","doi-asserted-by":"crossref","unstructured":"LC Cao, T Honeyman, J Jonassen, et al.  \"Kidney Int.\"  57, \"Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells.\" 2403 (2000)","DOI":"10.1046\/j.1523-1755.2000.00099.x"},{"key":"80","doi-asserted-by":"crossref","unstructured":"FC Huang, Y Du, XF Zhang, et al.  \"J Appl Toxicol.\"  \"SiO2 dust induces inflammation and pulmonary fibrosis in rat lungs through activation of ASMase\/ceramide pathway.\" (2023)","DOI":"10.1002\/jat.4467"},{"key":"81","doi-asserted-by":"crossref","unstructured":"I Petrache  and EV Berdyshev  \"Annu Rev Physiol.\"  78, \"Ceramide signaling and metabolism in pathophysiological states of the lung.\" 463 (2016)","DOI":"10.1146\/annurev-physiol-021115-105221"},{"key":"82","doi-asserted-by":"crossref","unstructured":"A Balogh, Y Shimizu, SC Lee, et al.  \"Cell Signal.\"  27, \"The autotaxin-LPA2 GPCR axis is modulated by \u03b3-irradiation and facilitates DNA damage repair.\" 1751 (2015)","DOI":"10.1016\/j.cellsig.2015.05.015"},{"key":"83","doi-asserted-by":"crossref","unstructured":"W Deng, DA Wang, E Gosmanova, et al.  \"Am J Physiol Gastrointest Liver Physiol.\"  284, \"LPA protects intestinal epithelial cells from apoptosis by inhibiting the mitochondrial pathway.\" G821 (2003)","DOI":"10.1152\/ajpgi.00406.2002"},{"key":"84","doi-asserted-by":"crossref","unstructured":"PK Shukla, AS Meena, R Gangwar, et al.  \"FASEB J.\"  34, \"LPAR2 receptor activation attenuates radiation-induced disruption of apical junctional complexes and mucosal barrier dysfunction in mouse colon.\" 11641 (2020)","DOI":"10.1096\/fj.202000544R"},{"key":"85","doi-asserted-by":"crossref","unstructured":"C Li, KS Dandridge, A Di, et al.  \"J Exp Med.\"  202, \"Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions.\" 975 (2005)","DOI":"10.1084\/jem.20050421"},{"key":"86","doi-asserted-by":"crossref","unstructured":"KE Thompson, RM Ray, S Alli, et al.  \"Exp Biol Med (May-wood).\"  243, \"Prevention and treatment of secretory diarrhea by the lysophosphatidic acid analog Rx100.\" 1056 (2018)","DOI":"10.1177\/1535370218803349"},{"key":"87","doi-asserted-by":"crossref","unstructured":"GJ Tigyi, LR Johnson, SC Lee, et al.  \"J Lipid Res.\"  60, \"Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential.\" 464 (2019)","DOI":"10.1194\/jlr.S091744"},{"key":"92","doi-asserted-by":"crossref","unstructured":"NV Gorbunov  and JG Kiang  \"Int J Mol Sci.\"  18, \"Ghrelin therapy decreases incidents of intracranial hemorrhage in mice after whole-body ionizing irradiation combined with burn trauma.\" (2017)","DOI":"10.3390\/ijms18081693"},{"key":"93","doi-asserted-by":"crossref","unstructured":"BJ Leibowitz, G Zhao, L Wei, et al.  \"Sci Adv.\"  7, \"Interferon beta drives intestinal regeneration after radiation.\" eabi5253 (2021)","DOI":"10.1126\/sciadv.abi5253"},{"key":"97","unstructured":"T Shea-Donohue, A Fasano, A Zhao, et al.  \"55th Annual Meeting of the Radiation Research Society; 2009.\"  \"An acute radiation syndrome (ARS) nonhuman primate (NHP) research platform: prolonged gastrointestinal (GI) dysfunction observed in NHPs surviving the acute heme and GI syndromes.\""},{"key":"98","doi-asserted-by":"crossref","unstructured":"M Akashi  and K Maekawa  \"J Radiol Prot.\"  41, \"Medical management of heavily exposed victims: an experience at the Tokaimura criticality accident.\" (2021)","DOI":"10.1088\/1361-6498\/ac270d"},{"key":"99","doi-asserted-by":"crossref","unstructured":"LP Taliaferro, RK Agarwal, CN Coleman, et al.  \"Int J Radiat Biol.\"  \"Sex differences in radiation research.\" (2023)","DOI":"10.1080\/09553002.2023.2283089"},{"key":"100","doi-asserted-by":"crossref","unstructured":"GH Anno, SJ Baum, HR Withers, et al.  \"Health Phys.\"  56, \"Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy.\" 821 (1989)","DOI":"10.1097\/00004032-198906000-00001"},{"key":"77","unstructured":"\"Fed Regist.\"  67, \"New drug and biological drug products; evidence needed to demonstrate effectiveness of new drugs when human efficacy studies are not ethical or feasible. Final Rule.\" 37988 (2002)"}],"container-title":["Radiation Research"],"original-title":[],"link":[{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-23-00196.1\/3356478\/10.1667_rade-23-00196.1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/radiation-research\/article-pdf\/doi\/10.1667\/RADE-23-00196.1\/3356478\/10.1667_rade-23-00196.1.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T02:55:48Z","timestamp":1716864948000},"score":1,"resource":{"primary":{"URL":"https:\/\/bioone.org\/journals\/radiation-research\/volume-201\/issue-6\/RADE-23-00196.1\/Gastrointestinal-Acute-Radiation-Syndrome--Mechanisms-Models-Markers-and-Medical\/10.1667\/RADE-23-00196.1.full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":103,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1667\/rade-23-00196.1","relation":{},"ISSN":["0033-7587"],"issn-type":[{"value":"0033-7587","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}